Elizabeth Calton

Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy

Judith Wienke, Lindy L. Visser, Waleed M. Kholosy et al. · Cancer Cell · 2024 · 101 citations · Full text

Life Sciences, Immunology, Oncology +17

<i>In Vivo</i> Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis

Orli Yogev, Gilberto S. Almeida, Karen Barker et al. · Cancer Research · 2019 · 80 citations · Full text

Medicine, Cancer Biology, Oncology +15

Orally bioavailable CDK9/2 inhibitor shows mechanism-based therapeutic potential in MYCN-driven neuroblastoma

Evon Poon, Tong Liang, Yann Jamin et al. · Journal of Clinical Investigation · 2020 · 70 citations · Full text

Medicine, Oncology, Pharmacology +16

Mutations in ALK signaling pathways conferring resistance to ALK inhibitor treatment lead to collateral vulnerabilities in neuroblastoma cells

Mareike Berlak, Elizabeth R. Tucker, Mathurin Dorel et al. · Molecular Cancer · 2022 · 59 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models

Elizabeth R. Tucker, Irène Jiménez, Lindi Chen et al. · Clinical Cancer Research · 2023 · 32 citations · Full text

Medicine, Oncology, Pharmacology +17